159 related articles for article (PubMed ID: 18973230)
1. Breast cancer susceptibility alleles and ovarian cancer risk in 2 study populations.
Gates MA; Tworoger SS; Terry KL; De Vivo I; Hunter DJ; Hankinson SE; Cramer DW
Int J Cancer; 2009 Feb; 124(3):729-33. PubMed ID: 18973230
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population.
Jara L; Gonzalez-Hormazabal P; Cerceño K; Di Capua GA; Reyes JM; Blanco R; Bravo T; Peralta O; Gomez F; Waugh E; Margarit S; Ibañez G; Romero C; Pakomio J; Roizen G
Breast Cancer Res Treat; 2013 Jan; 137(2):559-69. PubMed ID: 23225170
[TBL] [Abstract][Full Text] [Related]
3. Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases.
Huijts PE; Vreeswijk MP; Kroeze-Jansema KH; Jacobi CE; Seynaeve C; Krol-Warmerdam EM; Wijers-Koster PM; Blom JC; Pooley KA; Klijn JG; Tollenaar RA; Devilee P; van Asperen CJ
Breast Cancer Res; 2007; 9(6):R78. PubMed ID: 17997823
[TBL] [Abstract][Full Text] [Related]
4. Low-penetrance susceptibility variants and postmenopausal oestrogen receptor positive breast cancer.
Özgöz A; İçduygu FM; Yükseltürk A; ŞamlI H; Öztürk KH; Başkan Z
J Genet; 2020; 99():. PubMed ID: 32366738
[TBL] [Abstract][Full Text] [Related]
5. Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians.
Shan J; Mahfoudh W; Dsouza SP; Hassen E; Bouaouina N; Abdelhak S; Benhadjayed A; Memmi H; Mathew RA; Aigha II; Gabbouj S; Remadi Y; Chouchane L
Breast Cancer Res Treat; 2012 Oct; 135(3):715-24. PubMed ID: 22910930
[TBL] [Abstract][Full Text] [Related]
6. Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population.
Chan M; Ji SM; Liaw CS; Yap YS; Law HY; Yoon CS; Wong CY; Yong WS; Wong NS; Ng R; Ong KW; Madhukumar P; Oey CL; Tan PH; Li HH; Ang P; Ho GH; Lee AS
Breast Cancer Res Treat; 2012 Nov; 136(1):209-20. PubMed ID: 22965832
[TBL] [Abstract][Full Text] [Related]
7. Distribution of FGFR2, TNRC9, MAP3K1, LSP1, and 8q24 alleles in genetically enriched breast cancer patients versus elderly tumor-free women.
Gorodnova TV; Kuligina ESh; Yanus GA; Katanugina AS; Abysheva SN; Togo AV; Imyanitov EN
Cancer Genet Cytogenet; 2010 May; 199(1):69-72. PubMed ID: 20417875
[No Abstract] [Full Text] [Related]
8. Quantitative assessment of the effect of FGFR2 gene polymorphism on the risk of breast cancer.
Jia C; Cai Y; Ma Y; Fu D
Breast Cancer Res Treat; 2010 Nov; 124(2):521-8. PubMed ID: 20364400
[TBL] [Abstract][Full Text] [Related]
9. Predictive accuracy of the breast cancer genetic risk model based on eight common genetic variants: The BACkSIDE study.
Danková Z; Žúbor P; Grendár M; Zelinová K; Jagelková M; Stastny I; Kapinová A; Vargová D; Kasajová P; Dvorská D; Kalman M; Danko J; Lasabová Z
J Biotechnol; 2019 Jun; 299():1-7. PubMed ID: 31002855
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants in FGFR2 and TNRC9 genes are associated with breast cancer risk in Pakistani women.
Mazhar A; Jamil F; Bashir Q; Ahmad MS; Masood M; Tanvir I; Rashid N; Waheed A; Afzal MN; Tariq MA
Mol Med Rep; 2016 Oct; 14(4):3443-51. PubMed ID: 27572905
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer susceptibility variants alter risks in familial disease.
Latif A; Hadfield KD; Roberts SA; Shenton A; Lalloo F; Black GC; Howell A; Evans DG; Newman WG
J Med Genet; 2010 Feb; 47(2):126-31. PubMed ID: 19617217
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics.
Garcia-Closas M; Hall P; Nevanlinna H; Pooley K; Morrison J; Richesson DA; Bojesen SE; Nordestgaard BG; Axelsson CK; Arias JI; Milne RL; Ribas G; González-Neira A; Benítez J; Zamora P; Brauch H; Justenhoven C; Hamann U; Ko YD; Bruening T; Haas S; Dörk T; Schürmann P; Hillemanns P; Bogdanova N; Bremer M; Karstens JH; Fagerholm R; Aaltonen K; Aittomäki K; von Smitten K; Blomqvist C; Mannermaa A; Uusitupa M; Eskelinen M; Tengström M; Kosma VM; Kataja V; Chenevix-Trench G; Spurdle AB; Beesley J; Chen X; ; ; Devilee P; van Asperen CJ; Jacobi CE; Tollenaar RA; Huijts PE; Klijn JG; Chang-Claude J; Kropp S; Slanger T; Flesch-Janys D; Mutschelknauss E; Salazar R; Wang-Gohrke S; Couch F; Goode EL; Olson JE; Vachon C; Fredericksen ZS; Giles GG; Baglietto L; Severi G; Hopper JL; English DR; Southey MC; Haiman CA; Henderson BE; Kolonel LN; Le Marchand L; Stram DO; Hunter DJ; Hankinson SE; Cox DG; Tamimi R; Kraft P; Sherman ME; Chanock SJ; Lissowska J; Brinton LA; Peplonska B; Klijn JG; Hooning MJ; Meijers-Heijboer H; Collee JM; van den Ouweland A; Uitterlinden AG; Liu J; Lin LY; Yuqing L; Humphreys K; Czene K; Cox A; Balasubramanian SP; Cross SS; Reed MW; Blows F; Driver K; Dunning A; Tyrer J; Ponder BA; Sangrajrang S; Brennan P; McKay J; Odefrey F; Gabrieau V; Sigurdson A; Doody M; Struewing JP; Alexander B; Easton DF; Pharoah PD
PLoS Genet; 2008 Apr; 4(4):e1000054. PubMed ID: 18437204
[TBL] [Abstract][Full Text] [Related]
13. A study on genetic variants of Fibroblast growth factor receptor 2 (FGFR2) and the risk of breast cancer from North India.
Siddiqui S; Chattopadhyay S; Akhtar MS; Najm MZ; Deo SV; Shukla NK; Husain SA
PLoS One; 2014; 9(10):e110426. PubMed ID: 25333473
[TBL] [Abstract][Full Text] [Related]
14. Association between FGFR2 (rs2981582, rs2420946 and rs2981578) polymorphism and breast cancer susceptibility: a meta-analysis.
Zhang Y; Zeng X; Liu P; Hong R; Lu H; Ji H; Lu L; Li Y
Oncotarget; 2017 Jan; 8(2):3454-3470. PubMed ID: 27966449
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study.
Andersen SW; Trentham-Dietz A; Figueroa JD; Titus LJ; Cai Q; Long J; Hampton JM; Egan KM; Newcomb PA
Menopause; 2013 Mar; 20(3):354-8. PubMed ID: 23435034
[TBL] [Abstract][Full Text] [Related]
16. An investigation of the effects of FGFR2 and B7-H4 polymorphisms in breast cancer.
Ozgöz A; Samli H; Oztürk KH; Orhan B; Icduygu FM; Aktepe F; Imirzalioglu N
J Cancer Res Ther; 2013; 9(3):370-5. PubMed ID: 24125968
[TBL] [Abstract][Full Text] [Related]
17. Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women.
Rebbeck TR; DeMichele A; Tran TV; Panossian S; Bunin GR; Troxel AB; Strom BL
Carcinogenesis; 2009 Feb; 30(2):269-74. PubMed ID: 19028704
[TBL] [Abstract][Full Text] [Related]
18. Association of single nucleotide polymorphisms in FGF-RAS/MAP signalling cascade with breast cancer susceptibility.
Dankova Z; Zubor P; Grendar M; Kapinova A; Zelinova K; Jagelkova M; Gondova A; Dokus K; Kalman M; Lasabova Z; Danko J
Gen Physiol Biophys; 2017 Dec; 36(5):565-572. PubMed ID: 29372690
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide association study identifies novel breast cancer susceptibility loci.
Easton DF; Pooley KA; Dunning AM; Pharoah PD; Thompson D; Ballinger DG; Struewing JP; Morrison J; Field H; Luben R; Wareham N; Ahmed S; Healey CS; Bowman R; ; Meyer KB; Haiman CA; Kolonel LK; Henderson BE; Le Marchand L; Brennan P; Sangrajrang S; Gaborieau V; Odefrey F; Shen CY; Wu PE; Wang HC; Eccles D; Evans DG; Peto J; Fletcher O; Johnson N; Seal S; Stratton MR; Rahman N; Chenevix-Trench G; Bojesen SE; Nordestgaard BG; Axelsson CK; Garcia-Closas M; Brinton L; Chanock S; Lissowska J; Peplonska B; Nevanlinna H; Fagerholm R; Eerola H; Kang D; Yoo KY; Noh DY; Ahn SH; Hunter DJ; Hankinson SE; Cox DG; Hall P; Wedren S; Liu J; Low YL; Bogdanova N; Schürmann P; Dörk T; Tollenaar RA; Jacobi CE; Devilee P; Klijn JG; Sigurdson AJ; Doody MM; Alexander BH; Zhang J; Cox A; Brock IW; MacPherson G; Reed MW; Couch FJ; Goode EL; Olson JE; Meijers-Heijboer H; van den Ouweland A; Uitterlinden A; Rivadeneira F; Milne RL; Ribas G; Gonzalez-Neira A; Benitez J; Hopper JL; McCredie M; Southey M; Giles GG; Schroen C; Justenhoven C; Brauch H; Hamann U; Ko YD; Spurdle AB; Beesley J; Chen X; ; ; Mannermaa A; Kosma VM; Kataja V; Hartikainen J; Day NE; Cox DR; Ponder BA
Nature; 2007 Jun; 447(7148):1087-93. PubMed ID: 17529967
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of breast cancer susceptibility loci on 2q35, 3p24, 17q23 and FGFR2 genes in Taiwanese women with breast cancer.
Lin CY; Ho CM; Bau DT; Yang SF; Liu SH; Lin PH; Lin TH; Tien N; Shih MC; Lu JJ
Anticancer Res; 2012 Feb; 32(2):475-82. PubMed ID: 22287734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
